Giovanni Addolorato

Plain English
This study looked at the ongoing challenges faced by patients with liver diseases in Italy, focusing on issues like stigma, age-related concerns, economic barriers, gender differences, and quality of life. The researchers found that despite progress in treating conditions like hepatitis C, many patients still struggle to get diagnosed and manage their illnesses effectively. They proposed actionable solutions to improve care by addressing these unmet needs, recognizing that a collaborative approach involving various disciplines is essential. Who this helps: This helps patients with liver diseases and healthcare providers working to improve their care.

Plain English
This study looked at the challenges facing hospitals and healthcare systems, particularly in Italy, due to factors like aging populations, obesity, and complex health issues. It found that internists, or internal medicine doctors, play a crucial role in improving patient care and hospital efficiency through interventions like nutritional screening and coordinated care for obesity, which can reduce costs and enhance outcomes. Strengthening the role of internists is vital for maintaining effective universal healthcare systems and addressing health problems proactively. Who this helps: This benefits patients, hospital systems, and public health overall.

Plain English
This study focused on patients with peripheral arterial disease (PAD) and examined how alcohol use disorder (AUD) relates to the severity of their condition. Researchers found that 21.4% of the patients had AUD, and those with AUD were more likely to have severe PAD at presentation—36.4% had the most severe form of PAD compared to only 12.3% without AUD. These findings highlight the importance of screening for alcohol use problems in patients with PAD, as addressing AUD could improve care for these individuals. Who this helps: This helps patients with peripheral arterial disease and their doctors.

Plain English
This study looked at the effects of alcohol consumption on health, analyzing nearly 15,000 pieces of research. It found that higher alcohol intake leads to greater health risks, even at what many consider "moderate" levels, with injuries being 2.8 times more likely and serious liver disease risk significantly increasing for women at around 40 grams of alcohol per day. The results suggest that drinking less alcohol is better for health, highlighting the need for effective policies and counseling that promote lower alcohol use. Who this helps: This helps patients looking to improve their health and doctors guiding them on safer alcohol consumption.

Plain English
This research paper studies how fecal microbiota transplantation (FMT)—a process where healthy gut bacteria are transferred to someone else’s intestines—can help people with diabetes. The findings show that FMT can improve gut health, help control blood sugar levels, and influence immune system responses, especially in type 1 diabetes (T1D) and type 2 diabetes (T2D). In particular, people with T2D saw short-term benefits in insulin sensitivity, but the effects depended on their specific gut bacteria profiles. Who this helps: This helps patients with diabetes looking for new treatment options.

Plain English
This study looked at burnout, which is extreme stress and exhaustion, among young doctors in Italy who specialize in internal medicine. It found that 37.2% of these doctors reported experiencing burnout, especially those working long hours or in university hospitals, and only 2.8% had access to support systems to help them cope. This is important because addressing burnout can improve doctors' job satisfaction and patient care. Who this helps: This helps young internists and their hospitals.

Plain English
This study examined how resilience, or the ability to cope with stress, affects depression and anxiety in patients with inflammatory bowel diseases (IBD) like Crohn's disease and ulcerative colitis. Researchers found that patients with higher resilience reported fewer symptoms of depression and anxiety; for example, in Crohn's patients, those with high resilience experienced 72.6% fewer depressive symptoms and 66.8% fewer anxiety symptoms. This matters because it highlights the importance of building resilience as a way to improve mental health in IBD patients, especially when their disease is more active. Who this helps: This helps patients with inflammatory bowel diseases and their healthcare providers.

Plain English
This research looked at how metabolic and bariatric surgery not only helps with weight loss but also affects people's social and emotional lives. The findings show that after surgery, many individuals see improvements in their relationships, self-esteem, and social interactions, which are important for long-term success in maintaining weight loss. Understanding these broader effects is essential because they play a significant role in a person's overall well-being after surgery. Who this helps: This benefits patients undergoing weight loss surgery and their families.

Plain English
This study looked at how a specific blood test, called prothrombin time (BPT), could predict whether patients with severe alcohol-related hepatitis would respond to steroid treatment. Researchers found that out of 52 patients treated with steroids, 34 (or 65%) responded positively, while higher BPT levels indicated a greater chance of not responding, with a significant risk ratio of about 3 times higher for non-responders. This finding is important because it can help doctors quickly identify patients who aren't likely to benefit from steroids and may need alternative treatments, such as evaluating them for liver transplantation. Who this helps: This helps doctors and patients with severe alcohol-related hepatitis.

Plain English
This research looked at how low doses of alcohol might affect people with chronic liver disease. The findings show that while a few studies suggest that moderate drinking could benefit some patients with specific liver conditions, like non-alcoholic fatty liver disease (NAFLD), most evidence indicates that alcohol consumption generally worsens liver disease, particularly in those with chronic viral hepatitis. This matters because it highlights the need for caution and suggests there is no safe amount of alcohol for most patients with liver issues. Who this helps: This helps patients with chronic liver disease and their doctors make informed choices about alcohol consumption.

Plain English
This study looked at the safety of using a low dose of ondansetron, a medication typically used to treat nausea, for people with alcohol use disorder (AUD) and a specific genetic profile. The researchers found that this low dose did not significantly change liver health markers or cause major side effects in participants over 24 weeks. This matters because it suggests ondansetron could be a safe treatment option for those struggling with alcohol issues, especially as alcohol-related liver disease becomes more common. Who this helps: This helps patients with alcohol use disorder and liver disease.

Plain English
This study focuses on Alcohol Use Disorder (AUD), which is a major global health issue linked to early deaths and personal suffering. Researchers found that almost 90% of people with AUD do not receive proper treatment, largely due to stigma and limited access to effective therapies. They emphasize that treatment should not just aim for complete abstinence but also focus on reducing harm and improving overall mental health, suggesting that personalized treatment plans could greatly enhance outcomes. Who this helps: This helps patients with Alcohol Use Disorder and the healthcare providers treating them.

Plain English
This study looked at a 71-year-old man who had a fever, joint pain, and a serious skin ulcer after gardening, which turned out to be caused by a bite from a fiddleback spider. Doctors found that he developed a serious complication known as macrophage activation syndrome (MAS) and initially treated him with steroids, which helped his condition. Ultimately, the second biopsy revealed he also had a type of skin cancer called primary cutaneous anaplastic large cell lymphoma, emphasizing the importance of thorough testing for unexplained skin lesions and fevers. Who this helps: This research benefits patients with unexplained skin lesions and fevers, ensuring they receive accurate diagnoses and timely treatment.

Plain English
This study looked at how a low dose of ondansetron, a medication typically used for nausea, could help people with alcohol use disorder (AUD) who drink heavily. Over six months, people taking ondansetron experienced a 46.7% reduction in heavy drinking days compared to a 38.1% reduction for those on a placebo, meaning ondansetron was more effective. This matters because it offers a new treatment option that doesn't require people to stop drinking completely, which could make it easier for those struggling with alcohol addiction to get help. Who this helps: This benefits patients with alcohol use disorder, particularly those who drink heavily but are not ready to quit entirely.

Plain English
This study looked at why many adults referred for liver transplants aren't placed on the transplant list. Out of 314 patients evaluated, 54% were not listed for a transplant, with major reasons including psychological issues (9.3%), heart problems (6.8%), and issues with surgery (5.9%). Many referrals were found to be either inappropriate or too early, making up about 37% of the cases, and those sent from other hospitals were more likely to be non-listed. Who this helps: This information benefits patients needing liver transplants and doctors involved in their care.

Plain English
This research paper looks at the potential of a non-invasive test called shear wave dispersion elastography (SWD) for diagnosing alcohol-related liver disease (ALD) and compares it to a similar condition, metabolic dysfunction-associated steatotic liver disease (MASLD). The review found that while SWD shows promise in measuring liver stiffness and inflammation in MASLD, more work is needed to establish its effectiveness for ALD. Setting up specific guidelines for using SWD in ALD could lead to safer and cheaper diagnosis options for patients. Who this helps: Patients with alcohol-related liver disease and doctors evaluating their condition.

Plain English
This research looked at the various treatments for Alcohol Use Disorder (AUD) and found that a mix of biological and psychological strategies is essential for effective care. It highlighted new approaches targeting brain chemicals like Glutamate, which may help patients reduce alcohol use, and emphasized the need for personalized treatment based on individual factors, given the high number of people affected globally. Overall, the research suggests that tailored therapies can significantly improve outcomes for those struggling with alcohol dependence. Who this helps: This helps patients with Alcohol Use Disorder and healthcare providers in designing effective treatment plans.

Plain English
This research focused on sorghum, an ancient grain that could be a healthy addition to gluten-free diets for people with celiac disease (CD). It found that sorghum contains beneficial compounds that can help reduce inflammation, manage blood sugar, and lower cholesterol, making it potentially good for those struggling with CD. While there is some initial evidence that it can be safe for celiac patients, more long-term studies are needed to confirm its benefits. Who this helps: This research benefits patients with celiac disease who need gluten-free food options.

Plain English
This study looked at how effective sodium oxybate (SMO) is for treating alcohol dependence, depending on how severe a patient's drinking problem is and how long they receive treatment. Researchers found that patients with more severe alcohol dependence had a much better response to SMO, with a 216% higher rate of achieving abstinence compared to those with milder issues. Additionally, longer treatment durations increased the chances of staying sober, showing a benefit of about 11% for each extra month of treatment. Who this helps: This helps patients with severe alcohol dependence looking for effective treatment options.

Plain English
This study looked at alcohol-associated liver disease (ALD), which is a major cause of severe liver problems and death linked to the liver. It found that 75% of patients with serious liver damage are unaware of their condition until faced with a medical emergency. The research emphasizes the need for a combined treatment approach that addresses both the liver disease and the alcohol addiction to ensure better recovery. Who this helps: This helps patients with alcohol-associated liver disease and their healthcare providers.

Plain English
This study examined 423 patients with severe alcohol use disorder (AUD) to understand what factors lead some to also use other substances, a situation known as polysubstance use (PSU). It found that 115 of these patients, or about 27%, had PSU, and those with PSU reported much stronger cravings for rewards (like pleasure) from their substance use compared to those without PSU. Notably, earlier onset of alcohol use and higher rates of binge drinking were also linked to PSU. Understanding these cravings can help create more effective treatment plans for patients with both AUD and PSU. Who this helps: This research benefits patients struggling with severe alcohol use disorder and substance use issues, as well as their healthcare providers.

Plain English
This study examined how the peer review process in scientific research might be flawed, particularly in how negative results—findings that don't support a hypothesis—are reported and verified. The authors found that only 36% of influential studies were able to be replicated, raising concerns about the quality and reliability of published research. This matters because flawed studies can mislead scientists and hinder progress in understanding important issues. Who this helps: This helps researchers, policymakers, and ultimately patients by improving the reliability of scientific findings.

Plain English
This paper looks at acute alcohol intoxication, which can be very dangerous and even life-threatening due to excessive alcohol consumption. It highlights that severe cases can lead to serious health issues such as breathing difficulties, unconsciousness, and heart problems. The study emphasizes the importance of stabilizing patients in emergency departments and suggests using a drug called metadoxine to help speed up the removal of alcohol from the body. It also points out the need to assess whether these patients may have ongoing alcohol dependency issues for further treatment. Who this helps: This helps patients struggling with alcohol use and medical professionals treating them.

Plain English
This study looked at how early liver transplantation (eLT) can help patients with severe alcoholic hepatitis (sAH) in Italy. Researchers found that after eLT, all 16 patients survived for at least six months, while only 45% of similar patients who didn't receive a transplant survived that long. This is important because it shows that eLT can drastically improve survival chances for patients who don't respond to medical treatment for severe alcoholic hepatitis. Who this helps: This benefits patients with severe alcoholic hepatitis who do not improve with medical treatments.

Plain English
This research examined various medications used to treat Alcohol Use Disorder (AUD) to see how effective they are. The study found that approved medications like disulfiram, naltrexone, and acamprosate can effectively help many patients, but they are often underused, meaning many people with AUD do not get the help they need. Improving access to these treatments can lead to better recovery outcomes for patients struggling with alcohol use. Who this helps: This helps patients with alcohol use disorder and their doctors.

Plain English
The study focused on how the COVID-19 pandemic has affected people with alcohol-related liver disease (ALD) and alcohol use disorder (AUD). It found that isolation during the pandemic may have increased alcohol consumption, worsening liver health. Experts from the Italian Society on Alcohol developed new guidelines to manage ALD in patients with AUD during COVID-19, emphasizing safe treatment methods like telemedicine and better coordination among healthcare providers. Who this helps: This benefits patients with alcohol-related liver issues and their healthcare providers.

Plain English
This study looked at how common post-traumatic stress disorder (PTSD) and dissociative symptoms are in patients with inflammatory bowel disease (IBD) compared to healthy people. It found that IBD patients had much higher rates of these symptoms—about 40% experienced PTSD compared to only 10% in the healthy group—and those with Crohn's disease showed more symptoms when their disease was active. Understanding these psychological symptoms is important because they can impact the overall health and treatment of IBD patients. Who this helps: This helps patients with inflammatory bowel disease and their doctors.

Plain English
This study looked at how to treat people with alcohol use disorder (AUD) who also have liver problems caused by alcohol, known as alcohol-associated liver disease (ALD). It found that stopping alcohol use is crucial because continuing to drink leads to more severe health issues, such as a higher risk of death and the need for liver transplants. Despite the seriousness of the problem, standard medicines tested for AUD often exclude patients with ALD, making it unclear which treatments work best for them. Who this helps: This information benefits patients struggling with alcohol use and liver disease, as well as their doctors.

Plain English
This study looked at mental health issues, substance use, and self-harm among young people aged 10 to 24 in 31 European countries from 1990 to 2019. In 2019, there were about 17,000 cases of mental disorders, nearly 4,000 cases of substance use disorders, and about 89 cases of self-harm per 100,000 young people. The findings highlight a significant increase in certain disorders like eating disorders and drug use, especially in countries with fewer resources, showing that young people's mental health needs urgent attention and support. Who this helps: This helps patients, particularly young people facing mental health challenges.

Plain English
This study looked at the heart health of heavy drinkers over six months to understand early signs of alcoholic cardiomyopathy (ACM), a heart condition caused by excessive alcohol use. Researchers examined 43 patients and found that nearly half (46.5%) reduced their alcohol consumption during treatment. Initially, some heart measurements were higher than normal, indicating potential issues, but those who cut back on drinking saw significant improvement in their heart function after six months. Who this helps: This helps patients struggling with alcohol dependence and their doctors.

Plain English
This study focused on a medication called sodium oxybate (SMO) to help people who are dependent on alcohol stay sober. In a large trial with 314 participants, those who took SMO experienced on average 43.1 more days of sobriety during the treatment period compared to those taking a placebo. The positive effects of sodium oxybate continued even after stopping the medication, and it was generally well-tolerated by patients. Who this helps: This benefits patients struggling with alcohol dependence.

Plain English
This paper looked at how effective Transcranial Magnetic Stimulation (TMS) is for treating addictions to alcohol, tobacco, and cocaine. The findings indicate that TMS shows promise, with some clinical studies reporting positive results in reducing cravings and helping patients manage their addictions. This matters because there are very few effective medications available for treating these substance use disorders, and TMS could offer a new option for those struggling with addiction. Who this helps: This benefits patients with alcohol, tobacco, and cocaine addictions.

Plain English
This paper looks at a patient who had both colorectal cancer (CRC) and an infection from a specific type of bacteria called *Streptococcus gallolyticus subsp. pasteuranus*. The researchers found that there is a strong link between this type of infection and CRC, suggesting that if someone has this bacteria, they should be checked for cancer, ideally with a colonoscopy. They also highlight the need for more research into how gut bacteria might play a role in developing CRC. Who this helps: This helps patients who may be at risk for colorectal cancer and doctors diagnosing related infections.

Plain English
This study looked at the nutritional knowledge of over 2,500 Italian students from three provinces. It found that 60% of these students lacked adequate knowledge about healthy eating, despite most being at a normal weight and engaging in some physical activity. Improving nutritional education is important because it can help prevent chronic diseases in the future. Who this helps: This benefits students and educators by emphasizing the need for better nutrition education in schools.

Plain English
This study looked at a new formulation of sodium oxybate (SMO) to help people with alcohol dependence maintain their sobriety. Out of 509 patients treated for 12 weeks, those with severe alcohol dependence showed a significant improvement, with a 15% increase in the number of days they stayed sober compared to those not receiving the medication. However, overall results were mixed, partly because many participants on placebo also showed high levels of abstinence. Who this helps: This research benefits patients with severe alcohol dependence.

Plain English
This study looked at how the severity of alcohol dependence affects the response to placebo treatments in clinical trials. Researchers found that in trials involving more severe alcohol-dependent patients, only 16.8% achieved abstinence compared to 36.7% in less severe cases, indicating that more severe patients have a lower placebo response. Understanding this relationship can help improve the design of studies, making it easier to evaluate the effectiveness of new alcohol dependence treatments. Who this helps: This benefits researchers and pharmaceutical companies who are developing new treatments for alcohol dependence.

Plain English
This study looked at how two specific tests, Delta-Procalcitonin (Delta-PCT) and vitamin D levels, can help predict whether patients with sepsis in internal medicine will survive. Researchers found that patients with a significant drop in Delta-PCT levels after 48 to 96 hours had a much lower risk of dying in the next two to three months—only 0.12 times the risk if their levels dropped by more than 50%. Additionally, patients with severe vitamin D deficiency had nearly four times the risk of dying within 28 days compared to those with sufficient levels. Who this helps: This information is valuable for doctors treating hospitalized patients with sepsis, allowing them to assess the risk of mortality more effectively.

Plain English
This study looked at how sepsis, a serious infection, affects people with alcohol-related liver disease. Researchers found that patients with this condition have weakened immune systems and changes in gut bacteria, making them more prone to infections. Early and effective antibiotic treatment is crucial, as sepsis is particularly dangerous for these patients, and their chances of recovery are low. Who this helps: This helps patients with alcohol-related liver disease and their doctors.

Plain English
The study examined stress and burnout levels in 51 doctors working in COVID wards at Gemelli Hospital in Italy over a month. It found that doctors from specialties other than internal medicine experienced significantly higher emotional exhaustion, while attending physicians generally reported less burnout than residents. This research highlights that the type of medical specialty and the level of training can affect burnout risk among healthcare workers during a pandemic. Who this helps: This benefits doctors and hospital administrators looking to support physician well-being.

Plain English
This study looked at how many patients with celiac disease (CD) contracted COVID-19. Out of 542 CD patients, only 5 (0.92%) tested positive for the virus, and their infection rates were similar to those in the general population. However, CD patients were tested less frequently, which might explain why their positive test rate appeared higher. Who this helps: This research helps celiac disease patients by informing them about their COVID-19 risk.

Plain English
This research paper examined the global impact of cardiovascular diseases (CVDs), like heart disease and stroke, from 1990 to 2019. The study found that the number of people with CVD nearly doubled from 271 million in 1990 to 523 million in 2019, while deaths from CVD increased from 12.1 million to 18.6 million. This rise in disease burden highlights an urgent need for effective health policies to prevent these conditions and save lives, especially as CVD remains the top cause of death worldwide. Who this helps: This information benefits patients, healthcare providers, and policymakers focused on reducing heart disease and improving public health.